EA201070893A1 - Способы и композиции для лечения заболеваний костей - Google Patents

Способы и композиции для лечения заболеваний костей

Info

Publication number
EA201070893A1
EA201070893A1 EA201070893A EA201070893A EA201070893A1 EA 201070893 A1 EA201070893 A1 EA 201070893A1 EA 201070893 A EA201070893 A EA 201070893A EA 201070893 A EA201070893 A EA 201070893A EA 201070893 A1 EA201070893 A1 EA 201070893A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
compositions
treatment
present
bone diseases
Prior art date
Application number
EA201070893A
Other languages
English (en)
Other versions
EA020252B1 (ru
Inventor
Анне Схаафсма
Корнелис Глас
Элизабет Гертруда Хендрика Мария Ван Ден Хевел
Original Assignee
Фрисланд Брандз Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фрисланд Брандз Б.В. filed Critical Фрисланд Брандз Б.В.
Publication of EA201070893A1 publication Critical patent/EA201070893A1/ru
Publication of EA020252B1 publication Critical patent/EA020252B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к способам и композициям для лечения заболеваний костей, в частности потери костной массы, такой как остеопороз. В частности, настоящее изобретение относится к питательным композициям на основе молока, в которые предпочтительно добавлены пребиотики и отдельный источник витамина K, и способам применения таких питательных композиций для лечения или профилактики заболевания костей, в частности потери костной массы, такой как остеопороз. Композиция по настоящему изобретению включает одну или более фракций и/или компонентов молока; предпочтительно один или более пребиотиков; предпочтительно одну или более солей кальция и/или магния и витамин K(менахинон), включающий от 7 до 13 (от МК-7 до МК-13) изопропеноидных остатков.
EA201070893A 2008-01-28 2009-01-27 Способы и композиции для лечения заболеваний костей EA020252B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1034964A NL1034964C2 (nl) 2008-01-28 2008-01-28 Werkwijze en composities voor de behandeling van botaandoeningen.
PCT/EP2009/000578 WO2009095240A1 (en) 2008-01-28 2009-01-27 Methods and compositions for the treatment of bone conditions

Publications (2)

Publication Number Publication Date
EA201070893A1 true EA201070893A1 (ru) 2011-02-28
EA020252B1 EA020252B1 (ru) 2014-09-30

Family

ID=39727769

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070893A EA020252B1 (ru) 2008-01-28 2009-01-27 Способы и композиции для лечения заболеваний костей

Country Status (6)

Country Link
EP (1) EP2247199A1 (ru)
CN (1) CN101969792A (ru)
EA (1) EA020252B1 (ru)
MX (1) MX2010008144A (ru)
NL (1) NL1034964C2 (ru)
WO (1) WO2009095240A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119114A1 (en) * 2009-04-15 2010-10-21 Danisco A/S Bacterial strains having an outstanding ability to produce menaquinone
SG179065A1 (en) * 2009-09-14 2012-04-27 Nestec Sa Nutritional compositions including exogenous vitamin k2
WO2011150949A1 (en) 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2606118A1 (en) * 2010-08-17 2013-06-26 Chr. Hansen A/S Lactococcus lactis strain with high vitamin k2 production
US8765118B2 (en) 2010-08-17 2014-07-01 Chr. Hansen A/S Lactococcus lactis strain with high vitamin K2 production
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
WO2013144268A1 (en) * 2012-03-29 2013-10-03 Nestec S.A. Nutrition and exercise against drug-associated malnutrition in children
WO2013144267A2 (en) * 2012-03-29 2013-10-03 Nestec S.A. Improvement of musculoskeletal health by nutrition and exercise
CN114982971A (zh) * 2014-05-05 2022-09-02 巴斯夫欧洲公司 脂溶性维生素制剂
ITUA20163791A1 (it) * 2016-05-25 2017-11-25 Alfonso Colacchio Composto nutraceutico per il potenziamento del sistema immunitario ed il benessere delle ossa
CN106615099A (zh) * 2016-10-12 2017-05-10 西宝生物科技（上海）股份有限公司 一种包含mk‑7和活性维生素d3的酸奶及其制备方法
EP3572087B9 (en) 2017-01-23 2023-10-04 Cupione Co., Ltd. Composition for preventing or treating osteoarthritis containing sialyllactose or salt thereof as active ingredient
US20200338031A1 (en) * 2019-04-26 2020-10-29 Lanny Leo Johnson Compositions for the treatment of non-articular cartilage-associated bone conditions
AU2022213579A1 (en) * 2021-01-26 2023-08-10 Megmilk Snow Brand Co., Ltd. Composition for improving joint function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401958A (nl) * 1994-11-23 1996-07-01 Friesland Brands Bv Met eierschalenmeel verrijkt melkprodukt.
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
GB0100273D0 (en) * 2001-01-08 2001-02-14 Nestle Sa Nutritional composition for a bone condition
JP2006213627A (ja) * 2005-02-02 2006-08-17 Isamu Kajima 骨粗鬆症発症予防剤
JP5827784B2 (ja) * 2006-07-14 2015-12-02 ナットファルマ エーエスエー ビタミンｋ２を含む医薬及び栄養補助製品

Also Published As

Publication number Publication date
CN101969792A (zh) 2011-02-09
WO2009095240A1 (en) 2009-08-06
NL1034964C2 (nl) 2009-07-30
EP2247199A1 (en) 2010-11-10
MX2010008144A (es) 2010-08-04
EA020252B1 (ru) 2014-09-30

Similar Documents

Publication Publication Date Title
EA201070893A1 (ru) Способы и композиции для лечения заболеваний костей
TN2010000140A1 (en) Compositions and methods for use antibodies against sclerostin
MX2009008099A (es) Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
EA201200794A1 (ru) Триазолопиридины
EA201101475A1 (ru) Способы применения рецептора gpr119 для идентификации соединений, которые можно использовать для увеличения костной массы субъекта
WO2019092069A3 (en) Homovanillyl alcohol (hva), hva isomer, methods of making compositions comprising such compounds, and methods using such compounds
MX356584B (es) Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
WO2010130832A3 (en) Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
MA32257B1 (fr) Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques.
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
WO2010130830A3 (en) Anti-sclerostin vhh and their use for treating bone diseases
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
MX2014004722A (es) Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea.
TW200716172A (en) Pharmaceutical compositions for treating lower motor neuron diseases
JO2645B1 (en) Vehicles
GB0611907D0 (en) Compounds
CY1113726T1 (el) Χρηση της πασιρεοτιδης για την αντιμετωπιση της ενδογενους υπερινσουλιναιμικης υπογλυκαιμιας
UA113975C2 (xx) Застосування фармацевтичної композиції або добавки, яка містить фосфатидилсерин і куркумін (варіанти)
WO2008112840A3 (en) Novel composition and methods for the treatment of immune related diseases
GB0602639D0 (en) Organic compounds
UA101435C2 (ru) Аналоги нейропептида y, которые содержат по меньшей мере одну замену на синтетическую аминокислоту

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU